Autoantibodies as drivers of neuropathic pain
- PMID: 40744832
- DOI: 10.1016/j.molmed.2025.07.003
Autoantibodies as drivers of neuropathic pain
Abstract
Emerging evidence, supported by clinical responses to immunotherapy and the recapitulation of sensory symptoms in passive transfer models, shows that autoantibodies (AAbs) may drive neuropathic pain. These findings highlight the importance of immune profiling to enhance diagnosis and treatment, and provide molecular insights into broader pain mechanisms in clinical contexts.
Copyright © 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests The authors have no interests to declare.
LinkOut - more resources
Full Text Sources